"In the last 10-15 years, we have developed a whole class of drugs that allow us to bypass invasive approaches like splenectomy, or removal of the spleen." This was stated by Valerio De Stefano, professor of Hematology at the Catholic University of the Sacred Heart in Rome, during the 29th National Congress of the Italian Society for the Study of Hemostasis and Thrombosis.
https://www.youtube.com/watch?v=5p_Ez9CHly4
